PLIANT THERAPEUTICS, INC. Quarterly Operating Margin in % from Q4 2020 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Pliant Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2024.
  • Pliant Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2024 was -78.4K %, a 5328% decline year-over-year.
  • Pliant Therapeutics, Inc. annual Operating Margin for 2023 was -11.7K %, a 787% decline from 2022.
  • Pliant Therapeutics, Inc. annual Operating Margin for 2022 was -1.31K %, a 1.96% decline from 2021.
  • Pliant Therapeutics, Inc. annual Operating Margin for 2021 was -1.29K %, a 1193% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -78.4K -77K -5328% Jan 1, 2024 Mar 31, 2024
Q4 2023 -11.7K -10.3K -787% Oct 1, 2023 Dec 31, 2023
Q3 2023 -4.92K -3.75K -318% Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.16K -2.05K -184% Apr 1, 2023 Jun 30, 2023
Q1 2023 -1.44K +103 +6.63% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.31K -25.3 -1.96% Oct 1, 2022 Dec 31, 2022
Q3 2022 -1.18K -261 -28.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -1.11K -497 -80.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.55K -1.04K -208% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.29K -1.19K -1193% Oct 1, 2021 Dec 31, 2021
Q3 2021 -916 Jul 1, 2021 Sep 30, 2021
Q2 2021 -615 Apr 1, 2021 Jun 30, 2021
Q1 2021 -502 Jan 1, 2021 Mar 31, 2021
Q4 2020 -99.6 Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.